Unique Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UNIQUE PHARM, and what generic and branded alternatives to UNIQUE PHARM drugs are available?
UNIQUE PHARM has four approved drugs.
Drugs and US Patents for Unique Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Unique Pharm | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 217975-004 | Aug 21, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Unique Pharm | LORATADINE | loratadine | TABLET;ORAL | 214684-001 | Jan 7, 2021 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Unique Pharm | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 217975-005 | Aug 21, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Unique Pharm | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 217975-001 | Aug 21, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Unique Pharm | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 211623-002 | Apr 24, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.